AMBALAL SARABHAI ENTERPRISES
Back to Balance Sheet
|
AMBALAL SARABHAI ENTERPRISES Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹35 Cr | ₹29 Cr | ₹32 Cr | ₹35 Cr | ₹44 Cr |
What is the latest Contingent Liabilities ratio of AMBALAL SARABHAI ENTERPRISES ?
Year | Contingent Liabilities |
---|---|
Mar2025 | ₹35 Cr |
Mar2024 | ₹29 Cr |
Mar2023 | ₹32 Cr |
Mar2022 | ₹35 Cr |
Mar2021 | ₹44 Cr |
How is Contingent Liabilities of AMBALAL SARABHAI ENTERPRISES Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹35 Cr | 22.25 | |
Mar2024 | ₹29 Cr | -11.91 | |
Mar2023 | ₹32 Cr | -8.19 | |
Mar2022 | ₹35 Cr | -19.47 | |
Mar2021 | ₹44 Cr | - |
Compare Contingent Liabilities of peers of AMBALAL SARABHAI ENTERPRISES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AMBALAL SARABHAI ENTERPRISES | ₹273.8 Cr | -0.5% | -1% | -49.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹406,267.0 Cr | 0.7% | 2.8% | 7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹178,672.0 Cr | -0.8% | 3.7% | 48.6% | Stock Analytics | |
CIPLA | ₹119,713.0 Cr | -0.2% | -0.1% | -1.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,195.0 Cr | 3.4% | 11.2% | 17.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,999.0 Cr | 0.6% | -5.2% | -4.9% | Stock Analytics |
AMBALAL SARABHAI ENTERPRISES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AMBALAL SARABHAI ENTERPRISES | -0.5% |
-1% |
-49.8% |
SENSEX | -0.9% |
0.4% |
1.4% |
You may also like the below Video Courses